The risks of risk adjustment.
BACKGROUND
Risk adjustment is essential before comparing patient outcomes across hospitals. Hospital report cards around the country use different risk adjustment methods.


OBJECTIVE
To examine the history and current practices of risk adjusting hospital death rates and consider the implications for using risk-adjusted mortality comparisons to assess quality.


METHODS
This article examines severity measures used in states and regions to produce comparisons of risk-adjusted hospital death rates. Detailed results are presented from a study comparing current commercial severity measures using a single database. It included adults admitted for acute myocardial infarction (n=11880), coronary artery bypass graft surgery (n=7765), pneumonia (n=18016), and stroke (n=9407). Logistic regressions within each condition predicted in-hospital death using severity scores. Odds ratios for in-hospital death were compared across pairs of severity measures. For each hospital, z scores compared actual and expected death rates.


RESULTS
The severity measure called Disease Staging had the highest c statistic (which measures how well a severity measure discriminates between patients who lived and those who died) for acute myocardial infarction, 0.86; the measure called All Patient Refined Diagnosis Related Groups had the highest for coronary artery bypass graft surgery, 0.83; and the measure, MedisGroups, had the highest for pneumonia, 0.85 and stroke, 0.87. Different severity measures predicted different probabilities of death for many patients. Severity measures frequently disagreed about which hospitals had particularly low or high z scores. Agreement in identifying low- and high-mortality hospitals between severity-adjusted and unadjusted death rates was often better than agreement between severity measures.


CONCLUSIONS
Severity does not explain differences in death rates across hospitals. Different severity measures frequently produce different impressions about relative hospital performance. Severity-adjusted mortality rates alone are unlikely to isolate quality differences across hospitals.
Iezzoni
L I
LI
Department of Medicine, the Charles A. Dana Research Institute, Harvard Medical School, and Beth Israel Deaconess Medical Center, Boston, MA 02215, USA.
D019985:Benchmarking / Q000379:methods; D003953:Diagnosis-Related Groups; D019538:Health Care Surveys / Q000379:methods; D017052:Hospital Mortality; D006761:Hospitals / Q000592:standards*; D006801:Humans; D007255:Information Services; D016015:Logistic Models; D010043:Outcome and Process Assessment, Health Care / Q000379:methods*; D019984:Quality Indicators, Health Care; D018570:Risk Assessment; D012720:Severity of Illness Index; D014481:United States / Q000453:epidemiology